Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the allogeneic t cell therapies market grown over the years?

The allogeneic T cell therapies market has expanded rapidly, forecasted to rise from $1.16 billion in 2024 to $1.28 billion in 2025, at a CAGR of 10.0%. Key factors contributing to past growth include regulatory approvals, increasing cancer incidence, rising clinical trials, government funding, and an aging population.

What Is the forecasted market size and growth rate for the allogeneic t cell therapies market?

The allogeneic T cell therapies market is set to grow significantly, reaching $1.85 billion in 2029 at a CAGR of 9.8%. Factors contributing to growth include the expansion of indications, rising demand for cell-based immunotherapies, increasing awareness of advanced therapies, growing healthcare expenditure, and supportive reimbursement policies. Key trends include advancements in R&D, personalized medicine, off-the-shelf therapies, global market expansion, strategic partnerships, and regulatory changes.

Get your allogeneic t cell therapies market report here!

https://www.thebusinessresearchcompany.com/report/allogeneic-t-cell-therapies-global-market-report

What are the major factors driving growth in the allogeneic t cell therapies market?

The allogeneic T cell therapies market is set to grow due to the increasing cases of cancer, a disease caused by uncontrolled cell growth. Factors such as longer lifespans, lifestyle changes, environmental exposures, and genetic factors contribute to the rise in cancer cases. Allogeneic T cell therapies use genetically modified donor T cells to target and destroy cancer cells. The National Cancer Institute reported that the number of cancer survivors in the U.S. was approximately 18.1 million in May 2024, with projections reaching 22.5 million by 2032 and 29.9 million new cases annually by 2040.

What key areas define the segmentation of the global allogeneic t cell therapies Market?

The allogeneic t cell therapiesmarket covered in this report is segmented –

1) By Product Type: Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies, Other Product Types

2) By Antigen Type: CD 19, CD 20, Egfrvlll, GD2, CD22, CD30, CD33, Meso, HER1, Other Antigen Types

3) By Therapeutics Indications: Cancer, Autoimmune Diseases, Infectious Diseases, Others Therapeutics Indications

4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Chimeric Antigen Receptor (CAR) T Cell Therapies: CD19-targeted CAR T Therapies, BCMA-targeted CAR T Therapies, CD22-targeted CAR T Therapies

2) By T Cell Receptor (TCR) Therapies: Neoantigen-targeted TCR Therapies, Viral Antigen-targeted TCR Therapies

3) By Other Product Types: Engineered T Cell Therapies, NK Cell Therapies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18952&type=smp

What are the top market players propelling the growth of the allogeneic t cell therapies industry?

Major companies operating in the allogeneic t cell therapies market are Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences Inc., Immatics NV, Sangamo Therapeutics Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Atara Biotherapeutics Inc., Sorrento Therapeutics Inc., Autolus Therapeutics Plc, MaxCyte Inc., Tessa Therapeutics Pte Ltd., Cell Medica Inc., Enlivex Therapeutics Ltd., Cellectis SA, Adaptimmune Therapeutics Plc, Medigene AG, Celyad Oncology SA, Allogene Therapeutics Inc., Bellicum Pharmaceuticals Inc.

What are the key trends shaping the future of the allogeneic t cell therapies market?

Companies in the allogeneic T cell therapies market are advancing chimeric antigen receptor (CAR) T-cell therapy initiatives to improve treatment efficacy and expand therapeutic applications. These initiatives focus on enhancing the accessibility and effectiveness of CAR T-cell treatments for cancer. For example, in October 2022, Allogene Therapeutics Inc., a US-based biotechnology firm, introduced CAR T Together, an initiative aimed at addressing challenges in CAR T therapy delivery and access. This program streamlines clinical trial enrollment and fosters collaboration among oncologists to accelerate allogeneic CAR T therapy development. Unlike autologous therapies, which use a patient’s cells, allogeneic therapies rely on T cells from healthy donors, enabling more efficient manufacturing.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18952

What regions are dominating the allogeneic t cell therapies market growth?

North America was the largest region in the allogeneic T cell therapies market in 2024. The regions covered in the allogeneic T cell therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Autologous Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/autologous-cell-therapy-global-market-report

Cell and Gene Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Cellular Immunotherapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: